OliPass
Manufacturing · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
16-4 16 Beon-Gil Dongbaek Jungang-ro Fl ...Phone Number
+82 264882352Website
www.olipass.comRevenue
$6.3 MillionIndustry
ZI Rank: 1
About OliPass
OliPass Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OliPass your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if OliPass has recently received funding, and reach out quickly before it becomes old news!
Check out if OliPass is spiking on competitors!
Earning: See what the market has to say on OliPass recently announced quarterly report
Click to see if OliPass had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
OliPass, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when OliPass launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once OliPass has new funding data
Congratulate Masked Content for being promoted to Masked Content at OliPass
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
OliPass is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
OliPass is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about OliPass.
OliPass Tech Stack
A closer look at the technologies used by OliPass
Top Manufacturing Companies
Frequently Asked Questions Regarding OliPass
OliPass Corporation is a public biotech company listed in KOSDAQ in South Korea (ticker: KQ244460). The company is developing RNA therapeutics based on its proprietary oligonucleotide platform called OPNA (Olipass Peptide Nucleic Acid). OPNA was derived from PNA by rational chemical modifications in order to improve the cell permeability and RNA af... Read More
